Skin cancer vaccine: There may be a revolutionary turn in the treatment of skin cancer. The world's first individually tailored mRNA cancer vaccine, designed to treat melanoma, is being tested on patients in the UK. This 'game-changer' vaccine may help prevent not only melanoma but also bladder, lung, and kidney cancer in the future.
According to a BBC report, the special thing about this vaccine is that it is made separately for each patient. This vaccine gives the message to the body to identify cancer cells and fight them. Additionally, it also reduces the risk of cancer coming back in the future. Recently conducted second-stage test found that this vaccine significantly reduces the risk of cancer coming back in melanoma patients. After these good results, now the final test of this vaccine has been started.
Expert opinion
University College London Hospitals NHS Foundation Trust (UCLH) is leading this test. Dr. Heather Shaw, co-investigator of the trial, said that this is one of the most exciting things we have seen in a very long time. He further said that this is a very good device. Being able to tell your patients that you are giving them something that is so much more effective than standard cancer treatments. This is the same level of expertise that they are getting. These vaccines are highly technical and designed for each patient according to their condition. Patients are excited about it.
Hope for the future:
If the last stage test is also successful, then this vaccine can prove to be a milestone in the treatment of skin cancer. Also, it can mark a new beginning in the field of individually manufactured vaccines. In the coming time, this technology can also be used to treat other types of cancer.
